EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced Intake of Dietary Tryptophan Improves Beneficial Action of Budesonide in Patients with Lymphocytic Colitis and Mood Disorders

Cezary Chojnacki iD, Anita Gąsiorowska, Tomasz Popławski iD, Aleksandra Błońska, Paulina Konrad, Radosław Zajdler, Jan Chojnacki iD, Janusz Blasiak iD

Nutrients · 2023

DOI: 10.3390/nu15071674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Cezary Chojnacki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland. Hauptthemen laut MEDLINE: Tryptophan, Colitis, Lymphocytic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphocytic colitis (LC) is a gastrointestinal (GI) tract disease with poorly known pathogenesis, but some environmental and lifestyle factors, including certain dietary components, may play a role. Tryptophan is an essential amino acid, which plays important structural and functional roles as a component of many proteins. It is important in the development and maintenance of the body, in which it is metabolized in two main pathways: kynurenine (KYN) and serotonin. In this work, we explored the effect of reducing of TRP in the diet of patients with LC with mood disorders. We enrolled 40 LC patients who had a normal diet, 40 LC patients with the 8-week diet with TRP content reduced by 25% and 40 controls. All LC patients received budesonide at 9 mg per day, and the severity of their GI symptoms was evaluated by the Gastrointestinal Symptoms Rating Scale. Mood disorders were evaluated by the Hamilton Anxiety Rating Scale (HAM-A) and the Hamilton Depression Rating Scale (HAM-D). The concentration of TRP and its metabolites, 5-hydroxyindoleacetic acid (5-HIAA), kynurenine (KYN), kynurenic acid (KYNA) and quinolinic acid (QA), in urine were determined. Budesonide improved the GI and mental states of LC patients, and the diet with reduced TRP content further amended these symptoms. Dietary intervention decreased the concentration of 5-HIAA by about 50% (3.4 vs. 6.3) and QA by about 45% (3.97 vs. 7.20). These changes were correlated with a significant improvement in the profitable action of budesonide on gastrointestinal and mental health of LC patients as they displayed significantly lower GSRS, HAM-A and HAM-B scores after than before the intervention—10.5 vs. 32, 11.0 vs. 21 and 12 vs. 18, respectively. In conclusion, a reduction in TRP intake in diet may improve GI and mental symptoms in LC patients treated with budesonide and these changes may be mediated by the products of TRP metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TryptophanColitis, LymphocyticHumansKynurenineMood DisordersHydroxyindoleacetic AcidBudesonideDiet

Stichwörter der Autor:innen

anxiety and depressiondietary interventionfood intake controllymphocytic colitistryptophantryptophan metabolism

Substanzen

TryptophanKynurenineHydroxyindoleacetic AcidBudesonide

Autor:innen und Institutionen

  • Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland.
  • Department of Gastroenterology, Medical University of Lodz, 92-213 Lodz, Poland.
  • Department of Pharmaceutical Microbiology and Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland.
  • Department of Computer Science in Economics, University of Lodz, 90-237 Lodz, Poland.
  • Department of Molecular Genetics, University of Lodz, 90-236 Lodz, Poland.

ORCID-Profile: Cezary Chojnacki, Tomasz Popławski, Jan Chojnacki, Janusz Blasiak

Förderung

  • Medical University of Lodz

Zitieren

APA

Chojnacki, C., Gąsiorowska, A., Popławski, T., Błońska, A., Konrad, P., Zajdler, R., Chojnacki, J., & Blasiak, J. (2023). Reduced Intake of Dietary Tryptophan Improves Beneficial Action of Budesonide in Patients with Lymphocytic Colitis and Mood Disorders. Nutrients. https://doi.org/10.3390/nu15071674

Vancouver

Chojnacki C, Gąsiorowska A, Popławski T, Błońska A, Konrad P, Zajdler R, et al. Reduced Intake of Dietary Tryptophan Improves Beneficial Action of Budesonide in Patients with Lymphocytic Colitis and Mood Disorders. Nutrients. 2023. doi:10.3390/nu15071674

BibTeX
@article{Chojnacki2023,
  author = {Chojnacki, Cezary and Gąsiorowska, Anita and Popławski, Tomasz and Błońska, Aleksandra and Konrad, Paulina and Zajdler, Radosław and Chojnacki, Jan and Blasiak, Janusz},
  title = {Reduced Intake of Dietary Tryptophan Improves Beneficial Action of Budesonide in Patients with Lymphocytic Colitis and Mood Disorders},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15071674}
}
Kostenlos starten →